We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Employment Tribunal decision.
UK government and Valneva confirm multi-million-pound up-front investment in Livingston manufacturing facility.
First published during the 2019 to 2022 Johnson Conservative government
MOBILIST boosts growth in developing countries by investing in green infrastructure, technology and businesses.
Vulnerable women will be first to benefit from the pilot, which is part of the government’s response to Stephen Shaw’s latest review of immigration detention.
First published during the 2016 to 2019 May Conservative government
Upper Tribunal Tax and Chancery decision of Judge Timothy Herrington, Member Sue Dale and Member Gary Botterill on 04 May 2022
Pioneering treatment for multiple myeloma - partially-funded by an Innovate UK grant - reaches clinical stage.
Reports that rubber stopper may be pushed into vial during reconstitution, rendering the vial unusable. (EL (16)A/11)
Upper Tribunal Tax & Chancery decision of Judge Terence Mowschenson and Members Sandi O’Neill and Christopher Chapman on 6 AUGUST 2015.
Coadministration of a corticosteroid with an HIV-treatment-boosting agent may increase the risk of adrenal suppression due to a pharmacokinetic interaction.
The Defence and Security Accelerator recently launched the Enduring Challenge.
A launch event for the Enduring Challenge was held for science and technology providers on 26 January 2017.
(Novartis Pharmaceuticals UK) Increased risk of malignancies with long -term use of calcitonin – class 2 action within 48 hours. (EL 13(A)11)
North West handed significant boost with news that Alderley Park in Cheshire, is to host new centre in medicines technology.
First published during the 2015 to 2016 Cameron Conservative government
Upper Tribunal Tax and Chancery decision of Judge Mowschenson and Member O'Neill and Member Chapman on 6 August 2015.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).